![Camilla Soenderby](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Camilla Soenderby
Direktor/Vorstandsmitglied bei BB BIOTECH AG
Aktive Positionen von Camilla Soenderby
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BB BIOTECH AG | Direktor/Vorstandsmitglied | 21.03.2024 | - |
ABIVAX | Direktor/Vorstandsmitglied | 01.03.2024 | - |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Direktor/Vorstandsmitglied | 15.09.2021 | - |
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Camilla Soenderby
Ehemalige bekannte Positionen von Camilla Soenderby
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.01.2019 | 01.01.2020 |
Schering-Plough Ltd. (Taiwan)
![]() Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Part of Merck & Co., Inc., Schering-Plough Ltd. (Taiwan) is a Taiwanese company that sells and supplies pharmaceutical products. The company is based in Taipei, Taiwan. | Corporate Officer/Principal | - | - |
AbbVie SAS (France)
![]() AbbVie SAS (France) Medical DistributorsDistribution Services Part of AbbVie, Inc., AbbVie SAS (France) is a health endowment fund that supports general and innovative health projects in therapeutic areas such as virology, oncology, immunology, and neuroscience. The company is based in Rungis, France. The French company encourages actors in the field to improve the patient's journey and trust them. The company was founded in 2012. Sylvie Gregoire Huguel has been the CEO of the company since 2018. | Corporate Officer/Principal | - | - |
Shire France SAS
![]() Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.03.2018 | - |
Ausbildung von Camilla Soenderby
University of Copenhagen | Undergraduate Degree |
Statistik
International
Frankreich | 4 |
Schweiz | 2 |
Japan | 2 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Distribution Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BB BIOTECH AG | Finance |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
ABIVAX | Health Technology |
Private Unternehmen | 5 |
---|---|
Affibody Medical AB
![]() Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
F2G Ltd.
![]() F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
Shire France SAS
![]() Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Schering-Plough Ltd. (Taiwan)
![]() Schering-Plough Ltd. (Taiwan) Medical DistributorsDistribution Services Part of Merck & Co., Inc., Schering-Plough Ltd. (Taiwan) is a Taiwanese company that sells and supplies pharmaceutical products. The company is based in Taipei, Taiwan. | Distribution Services |
AbbVie SAS (France)
![]() AbbVie SAS (France) Medical DistributorsDistribution Services Part of AbbVie, Inc., AbbVie SAS (France) is a health endowment fund that supports general and innovative health projects in therapeutic areas such as virology, oncology, immunology, and neuroscience. The company is based in Rungis, France. The French company encourages actors in the field to improve the patient's journey and trust them. The company was founded in 2012. Sylvie Gregoire Huguel has been the CEO of the company since 2018. | Distribution Services |
- Börse
- Insiders
- Camilla Soenderby
- Erfahrung